Hangzhou Alltest Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 236.14 million compared to CNY 2,098.92 million a year ago. Revenue was CNY 236.14 million compared to CNY 2,098.92 million a year ago.

Net income was CNY 40.53 million compared to CNY 1,049.21 million a year ago. Basic earnings per share from continuing operations was CNY 0.5068 compared to CNY 13.1486 a year ago. Diluted earnings per share from continuing operations was CNY 0.5068.